Nordic Liposomes ApS: Financial statements 2023
CVR: 43161725
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Nordic Liposomes ApS (CVR 43161725) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 104,123 and a net result of DKK 67,655. Equity in the 2023 report amounted to DKK 39,874. The solvency ratio was 9.7%.
- Gross Profit
- DKK 104,123
- Profit/Loss
- DKK 67,655
- Equity
- DKK 39,874
- Total Assets
- DKK 412,136
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Nordic Liposomes ApS has published its interim report for the period March 28, 2022 to December 31, 2022.
About Nordic Liposomes ApS
Nordic Liposomes ApS is a Danish company of the type Anpartsselskab based in Søndersø, founded in 2022. The company is registered under the industry Andre fremstillingsaktiviteter i.a.n.. The company was previously named Nordicliposomes ApS. The management consists of Morten Thvilum and Trine Albers Huusfeldt. The company is owned by CIRRUS HOLDING ApS and Huusfeldt ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. Equity in the 2025 report amounted to DKK 443,608.
